309 related articles for article (PubMed ID: 33106822)
1. COVID-19 neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF; Lam EC; Astudillo MG; Yang D; Miller TE; Feldman J; Hauser BM; Caradonna TM; Clayton KL; Nitido AD; Murali MR; Alter G; Charles RC; Dighe A; Branda JA; Lennerz JK; Lingwood D; Schmidt AG; Iafrate AJ; Balazs AB
medRxiv; 2020 Oct; ():. PubMed ID: 33106822
[TBL] [Abstract][Full Text] [Related]
2. COVID-19-neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF; Lam EC; Astudillo MG; Yang D; Miller TE; Feldman J; Hauser BM; Caradonna TM; Clayton KL; Nitido AD; Murali MR; Alter G; Charles RC; Dighe A; Branda JA; Lennerz JK; Lingwood D; Schmidt AG; Iafrate AJ; Balazs AB
Cell; 2021 Jan; 184(2):476-488.e11. PubMed ID: 33412089
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.
Volk A; Covini-Souris C; Kuehnel D; De Mey C; Römisch J; Schmidt T
BioDrugs; 2022 Jan; 36(1):41-53. PubMed ID: 34843105
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020.
Zhang S; Ma P; Orzechowski M; Lemmer A; Rzasa K; Bagnall J; Barkho S; Chen M; He L; Neitupski R; Tran V; Ackerman R; Gath E; Bond A; Frongillo G; Cleland T; Golas A; Gaca A; Fitzgerald M; Kelly K; Hazegh K; Dumont L; Hoffman C; Homer M; Marks P; Woolley A; Wong S; Gomez J; Livny J; Hung D
mBio; 2023 Apr; 14(2):e0352322. PubMed ID: 36786604
[TBL] [Abstract][Full Text] [Related]
5. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
[TBL] [Abstract][Full Text] [Related]
6. Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.
da Silva ES; Kohnen M; Gilson G; Staub T; Arendt V; Hilger C; Servais JY; Charpentier E; Domingues O; Snoeck CJ; Ollert M; Seguin-Devaux C; Perez-Bercoff D
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887023
[TBL] [Abstract][Full Text] [Related]
7. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
Beaudoin-Bussières G; Laumaea A; Anand SP; Prévost J; Gasser R; Goyette G; Medjahed H; Perreault J; Tremblay T; Lewin A; Gokool L; Morrisseau C; Bégin P; Tremblay C; Martel-Laferrière V; Kaufmann DE; Richard J; Bazin R; Finzi A
mBio; 2020 Oct; 11(5):. PubMed ID: 33067385
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination.
Zedan HT; Smatti MK; Thomas S; Nasrallah GK; Afifi NM; Hssain AA; Abu Raddad LJ; Coyle PV; Grivel JC; Almaslamani MA; Althani AA; Yassine HM
JAMA Netw Open; 2023 Jun; 6(6):e2319222. PubMed ID: 37389876
[TBL] [Abstract][Full Text] [Related]
9. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Garcia-Beltran WF; Lam EC; St Denis K; Nitido AD; Garcia ZH; Hauser BM; Feldman J; Pavlovic MN; Gregory DJ; Poznansky MC; Sigal A; Schmidt AG; Iafrate AJ; Naranbhai V; Balazs AB
medRxiv; 2021 Mar; ():. PubMed ID: 33619506
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.
Merid Y; Tekleselasie W; Tesfaye E; Gadisa A; Fentahun D; Abate A; Alemu A; Mihret A; Mulu A; Gelanew T
Front Immunol; 2023; 14():1163688. PubMed ID: 37398668
[TBL] [Abstract][Full Text] [Related]
11. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
12. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Garcia-Beltran WF; Lam EC; St Denis K; Nitido AD; Garcia ZH; Hauser BM; Feldman J; Pavlovic MN; Gregory DJ; Poznansky MC; Sigal A; Schmidt AG; Iafrate AJ; Naranbhai V; Balazs AB
Cell; 2021 Apr; 184(9):2372-2383.e9. PubMed ID: 33743213
[TBL] [Abstract][Full Text] [Related]
13. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
[TBL] [Abstract][Full Text] [Related]
14. IgG Study of Blood Sera of Patients with COVID-19.
Kazachinskaia E; Chepurnov A; Shcherbakov D; Kononova Y; Saroyan T; Gulyaeva M; Shanshin D; Romanova V; Khripko O; Voevoda M; Shestopalov A
Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832577
[TBL] [Abstract][Full Text] [Related]
15. Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019.
Betton M; Livrozet M; Planas D; Fayol A; Monel B; Védie B; Bruel T; Tartour E; Robillard N; Manuguerra JC; Blanchard A; Ghosn J; Visseaux B; Péré H; Lebeaux D; Schwartz O; Veyer D; Hulot JS;
Clin Infect Dis; 2021 Sep; 73(6):e1337-e1344. PubMed ID: 33851216
[TBL] [Abstract][Full Text] [Related]
16. Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan.
Masood KI; Qaiser S; Abidi SH; Khan E; Mahmood SF; Hussain A; Ghous Z; Imtiaz K; Ali N; Hasan M; Memon HA; Yameen M; Ali S; Baloch S; Lakhani G; Alves PM; Iqbal NT; Ahmed K; Iqbal J; Bhutta ZA; Hussain R; Rottenberg M; Simas JP; Veldhoen M; Ghias K; Hasan Z
BMC Infect Dis; 2023 Dec; 23(1):846. PubMed ID: 38041026
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.
Gattinger P; Niespodziana K; Stiasny K; Sahanic S; Tulaeva I; Borochova K; Dorofeeva Y; Schlederer T; Sonnweber T; Hofer G; Kiss R; Kratzer B; Trapin D; Tauber PA; Rottal A; Körmöczi U; Feichter M; Weber M; Focke-Tejkl M; Löffler-Ragg J; Mühl B; Kropfmüller A; Keller W; Stolz F; Henning R; Tancevski I; Puchhammer-Stöckl E; Pickl WF; Valenta R
Allergy; 2022 Jan; 77(1):230-242. PubMed ID: 34453317
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.
Jennewein MF; MacCamy AJ; Akins NR; Feng J; Homad LJ; Hurlburt NK; Seydoux E; Wan YH; Stuart AB; Edara VV; Floyd K; Vanderheiden A; Mascola JR; Doria-Rose N; Wang L; Yang ES; Chu HY; Torres JL; Ozorowski G; Ward AB; Whaley RE; Cohen KW; Pancera M; McElrath MJ; Englund JA; Finzi A; Suthar MS; McGuire AT; Stamatatos L
Cell Rep; 2021 Jul; 36(2):109353. PubMed ID: 34237283
[TBL] [Abstract][Full Text] [Related]
19. RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers.
Aguilar R; Li X; Crowell CS; Burrell T; Vidal M; Rubio R; Jiménez A; Hernández-Luis P; Hofmann D; Mijočević H; Jeske S; Christa C; D'Ippolito E; Lingor P; Knolle PA; Roggendorf H; Priller A; Yazici S; Carolis C; Mayor A; Schreiner P; Poppert H; Beyer H; Schambeck SE; Izquierdo L; Tortajada M; Angulo A; Soutschek E; Engel P; Garcia-Basteiro A; Busch DH; Moncunill G; Protzer U; Dobaño C; Gerhard M
Microbiol Spectr; 2023 Feb; 11(1):e0316522. PubMed ID: 36622140
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration.
Simon G; Favresse J; Gillot C; Closset M; Catry É; Dogné JM; Douxfils J; Wieërs G; Bayart JL
Clin Chem Lab Med; 2023 Sep; 61(10):1875-1885. PubMed ID: 37078220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
